TREATMENT OF NEWLY DIAGNOSED FRAIL MULTIPLE MYELOMA PATIENTS WITH LENALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE

EHA Library, Maher Salamoon, 421493

HIGH BONE MARROW PLASMA CELL PERCENTAGE MAY IMPROVE THE R-ISS RISK STRATIFICATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A SINGLE-CENTRE REAL-WORLD EXPERIENCE IN CHINA

EHA Library, Ning Liu, 421494

REAL-WORLD EFFECTIVENESS AND SAFETY OF ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN CHINESE PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA: A SINGLE-ARM PROSPECTIVE STUDY

EHA Library, Weili Zhao, 421495

SPINAL -CORD COMPRESSION IN MULTIPLE MYELOMA . ALGERIAN MULTICENTER RETROSPECTIVE STUDY

EHA Library, Meriem benhalilou, 421496

EFFICACY AND SAFETY OF DARATUMUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MOROCCAN SINGLE-CENTER REAL-LIFE STUDY.

EHA Library, Yasmine MOUTMIR, 421497

DYNAMIC INCREASE IN SERUM CHOLESTEROL LEVELS CONTRIBUTES TO LONG-TERM REMISSION AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Yuan Chen, 421498

REAL-WORLD STUDY OF CARFILZOMIB-BASED CHEMOTHERAPY REGIMEN FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Li Hui, 421499

CLINICAL STUDY OF ORAL REGIMEN FOR ELDERLY REFRACTORY MULTIPLE MYELOMA

EHA Library, Yuping Zhong, 421500

GLOMERULAR PROTEINURIA IN PATIENTS WITH TRIPLE CLASS REFRACTORY MULTIPLE MYELOMA DURING BELANTAMAB MAFODOTIN TREATMENT: A SINGLE CENTER EXPERIENCE

EHA Library, Laura Pavan, 421502

A SINGLE-CENTER STUDY ON THE USE OF THALIDOMIDE MAINTENANCE THERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Lun-Wei Chiou, 421503

THE DIAGNOSTIC ENIGMA OF POEMS SYNDROME CASE SERIES FROM A SINGLE CENTRE

EHA Library, Bhavani Mandava, 421504

EXPRESSION AND PREDICTIVE VALUE OF CD24 ANTIGEN IN MULTIPLE MYELOMA PATIENTS

EHA Library, Mengru Liu, 421505

COMBINATION OF DARATUMUMAB AND BENDAMUSTINE IS AN EFFECTIVE TREATMENT FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Hong Cen, 421506

LIMITED EFFICACY OF DARATUMUMAB IN HIGH RISK RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS: A SINGLE CENTRE REAL-LIFE EXPERIENCE

EHA Library, Sonia Morè, 421507

AN ANALYSIS OF CLONAL ISOTYPE SWITCHING (CIS) FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS: A RETROS STUDY

EHA Library, LIJING SHEN, 421508

CLINICAL STUDY ON PROPHYLACTIC USE OF TPO-RA TO PROMOTE MEGAKARYOCYTE RECONSTRUCTION IN PATIENTS WITH MM AFTER ASCT

EHA Library, Juan Li, 421509

REAL WORLD UTILISATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA ACROSS EUROPE: A FEASIBILITY ASSESSMENT FOR THE MERMAID STUDY

EHA Library, Bruno Paiva, 421510

REAL-WORLD EVIDENCE EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Benjamin A Derman, 421511

EFFICACY OF MELFLUFEN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND MUTATED OR DELETED TP53

EHA Library, Klara ACS, 421512

RETROSPECTIVE OBSERVATIONAL STUDY OF THE TREATMENT OF WALDENSTRÖM'S MACROGLOBULINEMIA WITH IBRUTINIB IN ROUTINE CLINICAL PRACTICE IN SPAIN

EHA Library, Eva Rubio Azpeitia, 421513

EARLY UNITED STATES (US) USERS OF TALQUETAMAB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A REAL-WORLD ANALYSIS OF PATIENT CHARACTERISTICS AND TREATMENT HISTORY

EHA Library, Hoa Le, 421515

CPD-DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY RESULTS FROM THE CTRIAL-IE 19-17 STUDY SHOWS EARLY EVIDENCE OF EFFICACY

EHA Library, Janusz Krawczyk, 421516

ENHANCING BENEFIT-RISK ASSESSMENT IN MULTIPLE MYELOMA USING MULTI-STATE MODELING IN THE RANDOMIZED PHASE 3 EMN02/HO95 TRIAL.

EHA Library, Anna Smit, 421517

TRIAL IN PROGRESS: ALUMMINATE RRMM – A RANDOMIZED PHASE 3 STUDY OF ALNUCTAMAB, A BCMA-TARGETING T-CELL ENGAGER, VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY (RR) MULTIPLE MYELOMA (MM)

EHA Library, Noffar Bar, 421518

PLASMA CELL LEUKEMIA, REAL WORLD EXPERIENCE IN A MULTICENTER MEXICAN COHORT

EHA Library, Paulina Ramirez, 421520

POMA-BASED THERAPY AFTER DARATUMUMAB: A SINGLE CENTER EXPERIENCE

EHA Library, Martina Lorenzon, 421521

EFFICACY AND SAFETY OF CARFILZOMIB PLUS POMALIDOMIDE AND DEXAMETHASONE AS SALVAGE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN CHINA

EHA Library, Wenbin Qian, 421522

EFFICACY AND SAFETY OF THE CARFILZOMIB COMBINATION REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA IN CHINA: A REAL-WORLD ANALYSIS

EHA Library, Zhong-jun Xia, 421523

EFFICACY AND SAFETY OF CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE FOR THE TREATMENT OF POEMS SYNDROME

EHA Library, Hao Li, 421524

PROGNOSTIC VALUE OF HEMOGLOBINE TO RED CELL DISTRIBUTION WIDTH RATIO FOR PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Nikol Marošević, 421525

CHANGE OF ESTIMATED GLOMERULAR FILTRATION RATE ASSOCIATES WITH ALL-CAUSE MORTALITY IN MULTIPLE MYELOMA

EHA Library, Xiang Liu, 421527

DARATUMUMAB IS ONE OF THE MAIN DRIVERS OF OUTCOME IMPROVEMENT IN PATIENTS WITH AL AMYLOIDOSIS

EHA Library, Elena Alejo, 421528

DARATUMUMAB AND BORTEZOMIB AS MAINTENANCE IN NEWLY DIAGNOSED MYELOMA MULTIPLE IN NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION REAL LIFE PATIENTS.

EHA Library, María del Carmen Gilabert Gutiérrez, 421529

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE: INSIGHTS FROM A TERTIARY REFERRAL CENTER EXPERIENCE IN MEXICO

EHA Library, Sergio Rodriguez-Rodriguez, 421530

SECONDARY HYPOGAMMAGLOBULINEMIA ASSOCIATED WITH ANTI-CD38. EVALUATION OF CASES IN A HOSPITAL IN MADRID.

EHA Library, Gonzalo Benzo Callejo, 421531

REAL WORLD DATA OF RESPONSE TO DARATUMUMAB PLUS BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE (VTD) INDUCTION AND USE OF VTD AS BRIDGING CHEMOTHERAPY PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT (ASCT)

EHA Library, Sneha Fernandes, 421532

REAL-WORLD EXPERIENCE OF QUADRUPLET INDUCTION TREATMENT, DARA-VTD FOR UNTREATED TRANSPLANT ELIGIBLE MYELOMA PATIENTS IN A UK NHS CANCER CENTRE

EHA Library, Salam Youssef, 421533

THE POSSIBILITIES OF USING HIGH-THROUGHPUT SEQUENCING IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Daria Chebykina, 421534

COST AND HEALTHCARE UTILIZATION IN PATIENTS DIAGNOSED WITH MONOCLONAL GAMMOPATHY DURING THE EVALUATION OF ANEMIA

EHA Library, Mackenzie Maberry, 421535

SAFETY AND EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY MULTIPLE MYELOMA PATIENTS

EHA Library, arda bayar, 421536

6 CYCLES OF ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE (I-VRD) VS. 3 CYCLES OF I-VRD PLUS HIGH-DOSE MELPHALAN IN IN NEWLY DIAGNOSED LOW-RISK MULTIPLE MYELOMA. THE ELIAS-TRIAL.

EHA Library, Theo Leitner, 421537

C-MYC IS A PREDICTIVE FACTOR OF OUTCOMES IN TRANSPLANT ELIGIBLE ELDERLY MULTIPLE MYELOMA PATIENTS

EHA Library, Fatma Keklik Karadag, 421538

THE CLINICAL CHARACTERISTICS AND PROGNOSTIC MODELS OF PATIENTS WITH HIGH-RISK MULTIPLE MYELOMA WITH A TOTAL SURVIVAL PERIOD OF MORE THAN 3 YEARS.

EHA Library, Juan Li, 421539

MANAGEMENT OF MULTIPLE MYELOMA WITH RENAL FAILURE IN ALGERIA

EHA Library, S.M.Amine BENLAZAR, 421540

DOUBLE VERSUS SINGLE AUTOLOGOUS STEM CELL TRANSPLANT IN ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A REAL-WORLD MULTICENTRE REPORT

EHA Library, Danilo De Novellis, 421541

PREDICTORS OF RENAL RESPONSE AND SURVIVAL OUTCOMES IN CAST NEPHROPATHY

EHA Library, Wai Nga Grace Lau, 421543

EVALUATION OF ELRANATAMAB VS EPD, PVD, OR KD IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND PRIOR ANTI-CD38–DIRECTED THERAPY: MAGNETISMM-32

EHA Library, Satoshi Ito, 421544

AL AMYLOIDOSIS : BRIDGING GAPS IN KNOWLEDGE FOR IMPROVED PATIENT OUTCOMES : A RETROSPECTIVE REVIEW

EHA Library, amal chalbaoui, 421545

PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE WHO RESPOND TO SILTUXIMAB DEMONSTRATE SIGNIFICANT MEAN REDUCTION IN C-REACTIVE PROTEIN LEVELS COMPARED WITH SILTUXIMAB NON-RESPONDERS

EHA Library, JEANFRANCOIS ROSSI, 421546

DARATUMUMAB-BASED THERAPY IN PATIENTS WITH MULTIPLE MYELOMA AT FIRST RELAPSE/PROGRESSION: A MULTICENTER REAL-LIFE STUDY

EHA Library, Fengyan Jin, 421547

COMPREHENSIVE GERIATRIC ASSESSMENT AND CLINICAL OUTCOMES OF MULTIPLE MYELOMA PATIENTS IN A LATIN AMERICAN UNIVERSITY HOSPITAL

EHA Library, Claudia Sossa-Melo, 421548

A RETROSPECTIVE MULTICENTRE REAL-LIFE EXPERIENCE OF SAFETY OF SUBCUTANEOUS DARATUMUMAB IN PLASMA CELL DISORDERS

EHA Library, Danilo De Novellis, 421549

HETEROGENEITY AMONG FRAIL MYELOMA PATIENTS, FROM ‘FRAIL BASED ON AGE ALONE’ TO ‘ULTRA-FRAIL’, IS ASSOCIATED WITH CLINICAL OUTCOME

EHA Library, Kaz Groen, 421550

DEMOGRAPHIC AND BASELINE CHARACTERISTICS OF PATIENTS IN CARDIAC AMYLOID REACHING FOR EXTENDED SURVIVAL (CARES) PHASE 3 TRIALS ASSESSING SAFETY AND EFFICACY OF ANSELAMIMAB IN LIGHT CHAIN AMYLOIDOSIS

EHA Library, Ashutosh Wechalekar, 421551

CYTOMEGALOVIRUS REACTIVATION IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH DARATUMUMAB AS FIRST- OR SECOND-LINE THERAPY: A SINGLE INSTITUTION RETROSPECTIVE EXPERIENCE

EHA Library, Danilo De Novellis, 421552

MULTIPLE MYELOMA: 25-YEAR RETROSPECTIVE SINGLE-CENTER STUDY (ST. PETERSBURG, RUSSIA)

EHA Library, Sergey Voloshin, 421553

MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE IN A MEDIUM SIZED DISTRICT GENERAL HOSPITAL IN THE UNITED KINGDOM

EHA Library, Zarnain Syed, 421554

SINGLE-CENTER EXPERIENCE OF THERAPEUTIC INTENSIFICATION FOLLOWED BY AUTOTRANSPLANTATION OF NON-CRYOPOIETIC STEM CELLS IN MULTIPLE MYELOMA

EHA Library, Salima OUKID, 421555

IMPACT OF DARA-VTD INDUCTION THERAPY ON STEM CELL MOBILIZATION OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION: A MULTICENTER STUDY.

EHA Library, Roberta Della Pepa, 421556

HIGH RATES OF STRINGENT COMPLETE RESPONSE AND MRD NEGATIVITY AFTER DARATUMUMAB BASED INDUCTION QUADRUPLETS IN TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS (TE-NDMM) IN THE REAL-WORLD.

EHA Library, Grigorios Salvaras, 421557

CLINICAL OUTCOMES AND MICROBIOLOGICAL DATA IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY OF 92 SUBJECTS

EHA Library, Antonio Solimando, 421558

OUTCOME OF PATIENTS WITH MULTIPLE MYELOMA USING NON-CRYOPRESERVED STEM CELLS TRANSPLANT

EHA Library, Qudrat Ullah, 421559

EVALUATING MYOCARDIAL INVOLVEMENT IN PATIENTS WITH MULTIPLE MYELOMA AT DIFFERENT STAGES ：A CARDIAC MR T1 MAPPING STUDY

EHA Library, Peihong Guo, 421560

THE EFFECT OF CD38 EXPRESSION ON THE BONE MARROW PLASMA CELLS AFTER DARATUMUMAB TREATMENT ON DISEASE OUTCOME IN  MULTIPLE MYELOMA PATIENTS

EHA Library, Muhammed Enes CEYLAN, 421561

ISA-KD TREATMENT: EFFICACY IN MMRR PATIENTS WITH PRE-EXISTING SOFT-TISSUE PLASMACYTOMAS. REAL WORLD EVIDENCE.

EHA Library, María Dunia De Miguel Llorente, 421562

HEAVY/LIGHT CHAIN RESPONSE CRITERIA IN MULTIPLE MYELOMA CORRELATES BETTER WITH PROGNOSIS.

EHA Library, Sunil Lakhwani, 421563

DARATUMUMAB IN MULTIPLE MYELOMA. INITIAL EXPERIENCE IN A SINGLE CENTER IN CHILE.

EHA Library, Marcela Espinoza, 421564

A RETROSPECTIVE STUDY OF TREATMENT AND OUTCOMES OF AL AMYLOIDOSIS IN THE ERA OF MODERN DIAGNOSTICS AND NOVEL THERAPEUTIC AGENTS:  A TERTIARY CARE CENTRE EXPERIENCE FROM NORTHERN INDIA

EHA Library, PRIYANKA MOULE, 421565

DEVELOPMENT AND VALIDATION OF A NOVEL FRAILTY MODEL FOR PATIENTS WITH MULTIPLE MYELOMA

EHA Library, biao tian, 421566

LONG-TERM EFFICACY OF CAR-T THERAPY IN PATIENTS WITH FIRST RELAPSE OR PROGRESSIVE MULTIPLE MYELOMA

EHA Library, Yi Wang, 421567

SELINEXOR AND MELPHALAN CONDITIONING REGIMEN FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

EHA Library, Jiali Li, 421568

ABSENCE OF PROGRESSION WITHIN THREE YEARS MAY IDENTIFY A SUBGROUP OF LONG-TERM SURVIVORS WITH MULTIPLE MYELOMA

EHA Library, Shuangshuang Jia, 421569

MAGNETISMM-30: A PHASE 1B, OPEN-LABEL STUDY OF ELRANATAMAB IN COMBINATION WITH IBERDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Alexander Lesokhin, 421570

AL AMYLOID CARDIOMYOPATHY : UNVEILING THE CARDIAC IMPLICATIONS OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS

EHA Library, amal chalbaoui, 421571

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA PATIENTS WHOSE MYELOMA DEFINING EVENT WAS SLIM

EHA Library, Iuliana Vaxman, 421572

HEAVY/LIGHT CHAIN ANALYSIS CORRELATES WITH CLINICAL OUTCOMES IN MULTIPLE MYELOMA PATIENTS DURING THE DISEASE HISTORY

EHA Library, Cátia Almeida, 421573

PROGNOSTIC FACTORS INFLUENCING OVERALL SURVIVAL AND EVENT-FREE SURVIVAL IN ELDERLY WITH MULTIPLE MYELOMA

EHA Library, Bizid Inaam, 421574

POTENTIAL OF SERUM B-CELL MATURATION ANTIGEN LEVELS AS A DISEASE MONITORING BIOMARKER IN OLIGOSECRETORY RELAPSED MULTIPLE MYELOMA

EHA Library, Daisuke Ikeda, 421575

ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE IN NOT TRANSPLANT CANDIDATES RRMM. EXPERIENCE IN REAL WORLD EVIDENCE (RWE).

EHA Library, María Dunia De Miguel Llorente, 421576

COMPARATIVE EFFICACY OF TECLISTAMAB VERSUS POMALIDOMIDE PLUS DEXAMETHASONE FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA IN ENGLAND

EHA Library, Esther Cheah, 421577

SYSTEMIC MASTOCYTOSIS CLASSIFICATION AND TRYPTASE AND ß-2-MICROGLOBULINE LEVELS HELP IDENTIFY CASES IN WHICH PURIFICATION OF MAST CELLS CAN BE AVOIDED

EHA Library, Miguel Piris Villaespesa, 421578

PLATELET MULTI-OMICS ANALYSIS CONFIRMS HYPERGLYCEMIA AS A RISK FACTOR FOR THROMBOSIS IN JAK2V617F-POSITIVE ESSENTIAL THROMBOCYTHEMIA

EHA Library, Jia Chen, 421579

NATURAL KILLER CELLS IN MUTANT CALRETICULIN-DRIVEN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Theresa Harm, 421580

SINGLE-CELL RNA SEQUENCING REVEALS THE MOLECULAR AND CELLULAR HETEROGENEITY OF MAST CELLS IN SYSTEMIC MASTOCYTOSIS

EHA Library, Ken-Hong Lim, 421581

IMMUNE PROFILING OF PERIPHERAL BLOOD LEUKOCYTE SUBSETS IN INDOLENT SYSTEMIC MASTOCYTOSIS

EHA Library, Cecilia Karlström, 421582

PROTEOMIC AND FUNCTIONAL ANALYSIS OF PLATELETS FROM ESSENTIAL THROMBOCYTHEMIA PATIENTS

EHA Library, Petros Papadopoulos, 421583

COMPARISON OF THE ENZYMATIC AND CELLULAR PROFILES OF CLINICAL JAK2 INHIBITORS FOR THE TREATMENT OF MYELOFIBROSIS

EHA Library, Ricardo Macarron, 421584

ANALYSIS OF MONOCYTE SUBPOPULATIONS BY FLOW CYTOMETRY IN THE DIFFERENTIAL DIAGNOSIS OF CLONAL VERSUS REACTIVE MONOCYTOSIS IN BLOOD. EXPERIENCE IN A TERTIARY HOSPITAL.

EHA Library, Jose-Maria Raya, 421585

ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA SHOW DIFFERENT JAK2V617F CLONAL EXPANSION BETWEEN ERYTHROID AND PLATELET LINEAGES

EHA Library, Olivier Mansier, 421587

DECIPHERING THE SPLEEN MICROENVIRONMENT IN MYELOFIBROSIS WITH SPATIAL TRANSCRIPTOMIC

EHA Library, Edoardo Peroni, 421588

THA DYNAMICS OF STROMAL CELLS IN MYELOPROLIFERATIVE NEOPLASMS DURING THE MYELOFIBROSIS.

EHA Library, Keiki Nagaharu, 421589

PROTEOMIC ANALYSIS OF SERUM OF PATIENTS WITH SYSTEMIC MASTOCYTOSIS

EHA Library, Christos Fokoloros, 421590

THE JAK2 46/1 HAPLOTYPE INFLUENCES PD-L1 EXPRESSION

EHA Library, Gonzalo Carreno Gomez-Tarragona, 421592

PREDICTING CALR MUTATIONS IN MPN USING ROUTINE HEMATOXYLIN AND EOSIN (H&E)-STAINED BONE MARROW BIOPSIES

EHA Library, Saad Bashir, 421593

INTRACELLULAR FUMARATE ACCUMULATION IN MYELOFIBROSYS MESENCHYMAL STROMAL CELLS TRIGGERS CELL SENESCENCE AND FIBROSIS ONSET.

EHA Library, Sebastiano Giallongo, 421594

EVALUATION OF IL-3 RECEPTOR ALPHA CHAIN AS POTENTIAL TARGET IN ADVANCED SYSTEMIC MASTOCYTOSIS

EHA Library, Narges Aghaallaei, 421595

CLONAL EVOLUTION IN SECUNDARY ACUTE MYELOID LEUKEMIA ARISING FROM MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Sandra Martin, 421596

ALLELE POLYMORPHISM OF PLASMA HEMOSTATIC FACTORS GENES IN PRIMARY MYELOFIBROSIS

EHA Library, Natalia Korsakova, 421597

CLINICAL-PATHOLOGICAL CHARACTERIZATION OF MYELOPROLIFERATIVE AND MYELODEPLETIVE PHENOTYPES OF PRIMARY AND SECONDARY MYELOFIBROSIS

EHA Library, Simone Zoletto, 421598

UPREGULATION OF THE S100A8/S100A9 GENES LEADS TO RESISTANCE TO RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND MAY BE A DRIVING FACTOR IN BONE MARROW FIBROSIS.

EHA Library, Jian Huang, 421599